KR920703789A - 인체 염기성 fgf 뮤테인의 제조방법 - Google Patents

인체 염기성 fgf 뮤테인의 제조방법

Info

Publication number
KR920703789A
KR920703789A KR1019920701470A KR920701470A KR920703789A KR 920703789 A KR920703789 A KR 920703789A KR 1019920701470 A KR1019920701470 A KR 1019920701470A KR 920701470 A KR920701470 A KR 920701470A KR 920703789 A KR920703789 A KR 920703789A
Authority
KR
South Korea
Prior art keywords
amino acid
transformant
mutein
iptg
vector
Prior art date
Application number
KR1019920701470A
Other languages
English (en)
Inventor
가즈아끼 기따노
마사또 구리야마
오사무 니시무라
고이찌 이가라시
Original Assignee
모리따 가쓰라
다께다야꾸힝고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리따 가쓰라, 다께다야꾸힝고오교 가부시끼가이샤 filed Critical 모리따 가쓰라
Publication of KR920703789A publication Critical patent/KR920703789A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

인체 염기성 FGF 뮤테인의 제조방법
[도면의 간단한 설명]
제1도는 실시예 1에 사용된 rhbFGF 뮤테인 CS23의 DNA 뉴클레오티드 서열 및 뉴클레오티드 서열을 코딩하는 단백질의 아미노산 서열을 나타낸다,
제2도는 실시예 1에서 수득된 플라스미드 pTB960의 제작과정을 나타낸다,
제3도는 실시예 5에서 수득된 정제 시료의 SDS-PAGE 패턴 및 마커를 나타낸다.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. 성숙 인체 염기성 섬유아세포 성장 인자(hbFGF)의 적어도 하나의 구성 아미노산이 다른 아미노산으로 대체된 뮤테인의 코딩 뉴클레오티드 서열 및 그 상부의 T7프로모터를 함유하는 벡터.
  2. 제1항에 있어서, 적어도 하나의 구성 아미노산이 적어도 하나의 시스테인 잔기이고, 다른 아미노산이 세린 잔기인 벡터.
  3. 제1항에 있어서, 뮤테인이 성숙 hbFGF 구성 아미노산의 69- 및 87-위치의 시스테인 잔기가 세린 잔기로 대체된 뮤테인인 벡터.
  4. 제1항의 벡터에 의해 형질전환된 형질전환체.
  5. 제4항에 있어서, 숙주가 1ac 프로모터의 하부의 T7 RNA 폴리머라제 유전자를 갖는 에스케리키아 콜리(Escherichia coli)인 형질전환체.
  6. 제5항에 있어서, 이. 콜리(E. coli)MM 294(DE 3)/pCM 901의 특징을 갖는 형질전환체.
  7. 제5항에 있어서, 이 콜리(E. coli)MM 294(DE 3)/PCM 901의 특징을 갖는 형질전환체.
  8. 제4항의 형질전환체를 배지에서 배양함을 특징으로 하는, 성숙 hbFGF의 적어도 하나의 구성 아미노산이 다른 아미노산으로 대체된 뮤테인의 제조방법.
  9. 제항에 있어서, 제5하의 형질전환체의 대수성장기에 약 3-500μM의 이소프로필티오갈락토피라노시드(IPTG)를 배지에 가한 후 배양하는 방법.
  10. 제9항에 있어서, 3∼300μM의 IPTG를 사용하는 방법.
  11. 제10항에 있어서, 6∼200μM의 IPTG를 사용하는 방법.
  12. 제11항에 있어서, 6∼80μM의 IPTG를 사용하는 방법.
  13. 제8항에 있어서, 생성 뮤테인-함유 용액을 담체로 가교 다당류 황산염, 교환기로 술폰산기를 갖는 합성 중합체 및/또는 겔 여과용 합성 중합체를 사용하는 크로마토그래피에 의해 정제하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920701470A 1989-12-19 1990-12-18 인체 염기성 fgf 뮤테인의 제조방법 KR920703789A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP89-330225 1989-12-19
JP33022589 1989-12-19
PCT/JP1990/001646 WO1991009126A1 (en) 1989-12-19 1990-12-18 Production of human basic fgf mutein

Publications (1)

Publication Number Publication Date
KR920703789A true KR920703789A (ko) 1992-12-18

Family

ID=18230255

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701470A KR920703789A (ko) 1989-12-19 1990-12-18 인체 염기성 fgf 뮤테인의 제조방법

Country Status (7)

Country Link
EP (1) EP0506963A1 (ko)
JP (1) JP3130313B2 (ko)
KR (1) KR920703789A (ko)
CN (1) CN1055009A (ko)
CA (1) CA2070989A1 (ko)
HU (1) HUT64593A (ko)
WO (1) WO1991009126A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100374310B1 (ko) * 1995-02-14 2003-05-22 주식회사 엘지생명과학 변형된인간염기성섬유아세포성장인자및이의생산방법

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
EP1414866A2 (en) * 2000-11-21 2004-05-06 The Texas A & M University System Fgf-affinity chromatography
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8962556B2 (en) 2006-09-28 2015-02-24 Prochon Biotech Ltd. FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
DE102021211272A1 (de) 2021-10-06 2023-04-06 Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts Zusammensetzung enthaltend künstliche Sauerstoffträger zur Verhinderung von Organschäden in Transplantationsorganen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178863A1 (en) * 1984-10-15 1986-04-23 Schering Corporation Novel expression systems utilizing bacteriophage T7 promoters and gene sequences
DE3723992A1 (de) * 1987-07-20 1989-02-02 Boehringer Mannheim Gmbh Verfahren zur herstellung von proteinen in loeslicher form
JPH02504468A (ja) * 1987-11-24 1990-12-20 アムジエン・インコーポレーテツド 繊維芽細胞成長因子のアナログ
EP0326907A1 (en) * 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA and its use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100374310B1 (ko) * 1995-02-14 2003-05-22 주식회사 엘지생명과학 변형된인간염기성섬유아세포성장인자및이의생산방법

Also Published As

Publication number Publication date
CA2070989A1 (en) 1991-06-20
CN1055009A (zh) 1991-10-02
EP0506963A1 (en) 1992-10-07
HUT64593A (en) 1994-01-28
JP3130313B2 (ja) 2001-01-31
JPH05503006A (ja) 1993-05-27
WO1991009126A1 (en) 1991-06-27
HU9202039D0 (en) 1992-09-28

Similar Documents

Publication Publication Date Title
PT955313E (pt) Nova proteina e processo para a sua producao
DE69121391D1 (de) Methode zur ortsspezifischen änderung von rna und produktion von dadurch kodierten polypeptiden
DE69131580T2 (de) GDF-1 und UOG1 Proteine
KR880010130A (ko) 폴리 펩티드, dna 및 그의 용도
KR870009025A (ko) 재조합 숙주로부터 제조한 아프로티닌 동족체, 그의 방법, 표현 벡타 및 재조합 숙주 및 그의 재약상 용도
KR900700618A (ko) 인터루킨-1억제제
DE69020335T2 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
ATE380866T1 (de) Modulatoren des tnf-rezeptor-assoziierten faktors,deren herstellung und verwendungen
BR9802403A (pt) Proteìna tendo atividade transglutaminase, dna, transformante, e, processo para produzir uma proteìna tendo uma atividade transglutaminase.
KR950704497A (ko) 글리코실트랜스퍼라제 활성을 가진 단백질(Proteins Having Glycosyltransferase Activity)
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
KR920703789A (ko) 인체 염기성 fgf 뮤테인의 제조방법
KR940005799A (ko) 거핵구 분화 인자
KR930010177A (ko) 하이브리드 형질전환 성장인자
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
DK120290A (da) Nye derivater af human/bovin basal fibroblastvaekstfaktor
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
WO1990004035A1 (en) Recombinant pdgf and methods for production
CA2005154A1 (en) Method for purifying fibroblast growth factor protein
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
US5395756A (en) Production of acidic FGF protein
DE69115270T2 (de) Protein mit fibroblasten-wachstumsfaktor-rezeptoraktivität.
BR1100940A (pt) Polipeptìdeos puros, sequências adn, molécula adn recombinada, célula hospedeira, processo de manipulação genética para produção de polipeptìdeo, e, uso de um polipeptìdeo
KR890013177A (ko) 신규폴리펩티드 및 그것을 코우드하는 dna
JPH0541988A (ja) ラツトｂＦＧＦ蛋白質の製造法

Legal Events

Date Code Title Description
SUBM Submission of document of abandonment before or after decision of registration